ASX 200 8,124.50 ▲ +1.2% AUD/USD 0.6542 ▼ -0.3% BHP $45.20 ▲ +2.1% CBA $112.80 ▲ +0.8% Gold $2,342 ▲ +0.5% Iron Ore $108.50 ▼ -1.1% CSL $298.40 ▲ +1.5% Oil (Brent) $82.30 ▼ -0.4% ASX 200 8,124.50 ▲ +1.2% AUD/USD 0.6542 ▼ -0.3% BHP $45.20 ▲ +2.1% CBA $112.80 ▲ +0.8% Gold $2,342 ▲ +0.5% Iron Ore $108.50 ▼ -1.1% CSL $298.40 ▲ +1.5% Oil (Brent) $82.30 ▼ -0.4%
•
Subscribe Newsletter
Home → Companies → OPT
OPT Health Care Sector News

Opthea Ltd

About OPT

A biopharmaceutical company researching therapies targeting VEGF-C, D, and R3 for serious retinal diseases, with its lead candidate sozinibercept being developed as a combination treatment for wet AMD and related conditions.

All News for OPT

No news articles found for OPT yet.

Company Stats

ASX Code OPT
Sector Health Care Sector News
Total Articles 0
Latest News N/A

🏢 Related Companies

1AD Adalta Ltd AFP Aft Pharmaceuticals Ltd ATH Alterity Therapeutics Ltd AVR Anteris Technologies Global Co... CC5 Clever Culture Systems Ltd COH Cochlear Ltd CYC Cyclopharm Ltd DXB Dimerix Ltd